Shares of Terumo Corp. (OTCMKTS:TRUMY - Get Free Report) saw unusually-high trading volume on Wednesday . Approximately 636,787 shares traded hands during trading, an increase of 289% from the previous session's volume of 163,727 shares.The stock last traded at $17.38 and had previously closed at $15.97.
Terumo Stock Down 0.6%
The firm's 50 day moving average is $17.76 and its two-hundred day moving average is $18.36. The firm has a market cap of $25.85 billion, a P/E ratio of 33.58 and a beta of 0.79. The company has a current ratio of 3.00, a quick ratio of 1.78 and a debt-to-equity ratio of 0.12.
Terumo (OTCMKTS:TRUMY - Get Free Report) last announced its earnings results on Wednesday, May 14th. The company reported $0.08 EPS for the quarter, missing the consensus estimate of $0.15 by ($0.07). The company had revenue of $1.79 billion for the quarter, compared to analyst estimates of $1.79 billion. Terumo had a return on equity of 8.48% and a net margin of 11.28%.
Terumo Company Profile
(
Get Free Report)
Terumo Corporation engages in the manufacture and sale of medical products and equipment in Japan, Europe, China, the United States, Asia, and internationally. The company operates through three segments: Cardiac and Vascular Company, Medical Care Solutions Company, and Blood and Cell Technologies Company.
Further Reading
Before you consider Terumo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Terumo wasn't on the list.
While Terumo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access